Chembond Chemic.

Why is Chembond Chemicals Ltd falling/rising?

As of 19-Aug, Chembond Chemicals Ltd's stock price is rising to Rs 272.50, reflecting a 2.64% increase. This rise is driven by strong past performance, positive technical indicators, and proximity to a 52-week high, despite a significant drop in investor participation.

As of 19-Aug, Chembond Chemicals Ltd's stock price is rising, currently at Rs 272.50, reflecting a change of Rs 7.0 or 2.64% increase. This upward movement can be attributed to several factors. The stock has shown strong performance over the past month, with a gain of 10.75%, significantly outperforming the Sensex, which declined by 1.59% during the same period. Year-to-date, the stock has surged by 79.28%, while the Sensex has fallen by 9.75%, indicating robust investor confidence in Chembond Chemicals.<BR><BR>Additionally, the stock has been gaining for the last two days, with a total return of 3.87% in this period. It is also trading above its moving averages across multiple time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a positive trend. Furthermore, the stock is close to its 52-week high, being only 3.85% away from Rs 283, which may attract more investors looking for upward momentum.<BR><BR>Despite a notable drop in investor participation, with delivery volume falling by 96.8% against the 5-day average, the stock remains liquid enough for trading. Overall, the combination of strong historical performance, positive technical indicators, and proximity to a 52-week high contributes to the rising stock price of Chembond Chemicals Ltd.

Which are the latest news on Chembond Chemic.?

What does Chembond Chemic. do?

Chembond Chemicals Ltd is a micro-cap company in the specialty chemicals industry, reporting net sales of 86 Cr and a net profit of 10 Cr for June 2026. Key metrics include a P/E ratio of 20.00 and a market cap of INR 740 Cr.

Overview:<BR>Chembond Chemicals Ltd operates in the specialty chemicals industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The incorporation year and any status changes are not provided. The latest quarterly results reported are for June 2026, showing net sales and profit figures.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 86 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 10 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 740 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 20.00 <BR>Industry P/E: 44 <BR>Dividend Yield: 0.46% <BR>Debt-Equity: -0.32 <BR>Return on Equity: 16.90% <BR>Price-to-Book: 3.57 <BR><BR>Contact Details:<BR>Registrar Address: Not available. <BR>Phone: Not available. <BR>Email: Not available. <BR>Website: Not available.

Who are the peers of the Chembond Chemic.?

Chembond Chemic.'s peers include Valiant Organics, Fairchem Organic, Gem Aromatics, Sudarshan Pharma, DMCC Speciality, Chemcon Special., Jayant Agro Org., Kronox Lab, and Black Rose Indus. Chembond Chemic. has a 1-year return of 50.46%, outperforming its peers, with Sudarshan Pharma at 20.20% and Fairchem Organic at -15.40%.

Peers: The peers of Chembond Chemic. are Valiant Organics, Fairchem Organic, Gem Aromatics, Sudarshan Pharma, DMCC Speciality, Chemcon Special., Jayant Agro Org., Kronox Lab, and Black Rose Indus.<BR><BR>Quality Snapshot: Excellent management risk is observed at Chemcon Special., Kronox Lab, and Black Rose Indus, while Average management risk is found at Fairchem Organic, Gem Aromatics, Sudarshan Pharma, DMCC Speciality, Jayant Agro Org., and the rest. Below Average management risk is noted for Valiant Organics. Growth ratings show Excellent growth at Sudarshan Pharma, Average growth at Fairchem Organic, Gem Aromatics, DMCC Speciality, Jayant Agro Org., and the rest, and Below Average growth at Valiant Organics. In terms of Capital Structure, Excellent capital structure is seen at Chembond Chemic., Chemcon Special., Kronox Lab, and Black Rose Indus, while Good capital structure is noted for Fairchem Organic, Gem Aromatics, and Jayant Agro Org., and Average capital structure is found at Valiant Organics and DMCC Speciality.<BR><BR>Return Snapshot: Chembond Chemic. has a 1-year return of 50.46%, which is higher than the peer with the highest return, Sudarshan Pharma, at 20.20%, and significantly higher than the peer with the lowest return, Fairchem Organic, at -15.40%. Additionally, Chemcon Special. and Fairchem Organic have negative six-month returns.

How big is Chembond Chemic.?

As of 14th August, Chembond Chemicals Ltd has a market capitalization of 718.00 Cr and reported net sales of 347.25 Cr and net profit of 38.25 Cr over the latest four quarters.

As of 14th August, <BR><BR>Market Cap: Chembond Chemicals Ltd has a market capitalization of 718.00 Cr, categorized as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 347.25 Cr, while the sum of Net Profit for the same period is 38.25 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2026, with Shareholder's Funds amounting to 206.99 Cr and Total Assets valued at 251.76 Cr.

Should I buy, sell or hold Chembond Chemicals Ltd?

Are Chembond Chemicals Ltd latest results good or bad?

Chembond Chemicals Ltd's latest results show strong year-on-year growth with a 52.24% increase in net profit and a 32.27% rise in net sales. However, there are concerns due to sequential declines in both profit and revenue, along with a decrease in operating margin, indicating potential volatility and operational challenges.

Chembond Chemicals Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹9.53 crores for Q1 FY27, which is a significant increase of 52.24% year-on-year. Additionally, net sales grew by 32.27% year-on-year to ₹86.48 crores, indicating strong demand and market growth.<BR><BR>However, there are notable concerns regarding sequential performance. Both net profit and revenue saw declines of 18.76% and 14.70% respectively compared to the previous quarter. This indicates volatility in the company's performance, which is common in the specialty chemicals sector. Furthermore, the operating margin decreased from 15.66% in Q4 FY26 to 13.10% in Q1 FY27, suggesting a deterioration in operational efficiency.<BR><BR>Overall, while the year-on-year growth figures are impressive, the sequential declines raise questions about the sustainability of this growth and operational stability. Investors may want to keep an eye on these trends moving forward.

When is the next results date for Chembond Chemicals Ltd?

The next results date for Chembond Chemicals Ltd is 16 July 2026.

The next results date for Chembond Chemicals Ltd is scheduled for 16 July 2026.

How has been the historical performance of Chembond Chemic.?

Chembond Chemic's historical performance has shown fluctuations, with the latest fiscal year (ending March 2025) reporting net sales of 292.27 crore, a profit after tax of 30.92 crore, and an EPS of 11.54, indicating a recovery in profitability and stable operations. Total assets and liabilities were balanced at 213.51 crore, with positive cash flow from operations.

Answer:<BR>The historical performance of Chembond Chemic shows a mixed trend over the years, with significant fluctuations in key financial metrics.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Chembond Chemic reported net sales of 292.27 crore and total operating income of the same amount. The total expenditure, excluding depreciation, was 250.34 crore, leading to an operating profit (PBDIT) of 41.93 crore, which increased to 47.76 crore when including other income. The profit before tax stood at 42.17 crore, resulting in a profit after tax of 30.92 crore, and a consolidated net profit of 31.04 crore. The earnings per share (EPS) for this period was 11.54, with a profit after tax margin of 10.58%. On the balance sheet, total assets were recorded at 213.51 crore, while total liabilities were 213.51 crore, indicating a balanced position. The company's shareholder's funds increased to 174.21 crore, with total reserves at 160.76 crore. Cash flow from operating activities showed a positive trend with a cash flow of 9.00 crore, while the net cash inflow was 7.00 crore. Overall, the financial data reflects a recovery in profitability and a stable operational performance in the latest fiscal year, despite previous years showing more volatility in both profits and assets.

Is Chembond Chemic. overvalued or undervalued?

As of August 29, 2025, Chembond Chemic. is considered a very attractive investment due to its undervaluation compared to peers, with a PE Ratio of 16.03, an EV to EBITDA of 10.41, and a strong ROCE of 32.77%, despite recent stock performance lagging behind the Sensex.

As of 29 August 2025, the valuation grade for Chembond Chemic. has moved from does not qualify to very attractive, indicating a significant improvement in its investment appeal. The company is currently assessed as undervalued, particularly when compared to its peers in the specialty chemicals sector. Key ratios include a PE Ratio of 16.03, an EV to EBITDA of 10.41, and a ROCE of 32.77%, showcasing strong operational efficiency and profitability.<BR><BR>In comparison with peers, Chembond Chemic. stands out with a much lower PE Ratio than Solar Industries, which has a PE of 98.93, and Godrej Industries at 40.99. The PEG Ratio for Chembond is notably at 0.00, suggesting that the stock is priced attractively relative to its growth potential. While the recent stock performance has lagged behind the Sensex, with a 1-week return of -14.8% compared to -1.84% for the index, the overall valuation metrics indicate that Chembond Chemic. presents a compelling investment opportunity in its sector.